Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis
- 1 September 2002
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 44 (1) , 51-57
- https://doi.org/10.1016/s0732-8893(02)00416-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Population Pharmacokinetics of Continuous Infusion Piperacillin-TazobactamJournal of Infectious Disease Pharmacotherapy, 2002
- Divergence in MIC Distributions of Pseudomonas aeruginosa for Piperacillin and Piperacillin/TazobactamJournal of Infectious Disease Pharmacotherapy, 2001
- Pharmacokinetic and Economic Evaluation of Piperacillin/Tazobactam Administered as Either Continuous or Intermittent Infusion with Once-Daily GentamicinInfectious Diseases in Clinical Practice, 1999
- CONTINUOUS VS. INTERMITTENT INFUSION OF CEFUROXIME FOR THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIAInfectious Diseases in Clinical Practice, 1998
- The Pharmacodynamics of β‐LactamsClinical Infectious Diseases, 1998
- Treatment of Ventilator‐Associated Pneumonia with Piperacillin‐Tazobactam/Amikacin Versus Ceftazidime/Amikacin: A Multicenter, Randomized Controlled TrialClinical Infectious Diseases, 1998
- Continuous Infusion β-LactamsInfectious Diseases in Clinical Practice, 1996
- Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or bothJournal of Antimicrobial Chemotherapy, 1995
- Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal ModelThe Journal of Infectious Diseases, 1988
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976